Next-Generation Sequence Detects ARAP3 as a Novel Oncogene in Papillary Thyroid Carcinoma Retraction

Key Points

• This research aimed to identify novel oncogenes in papillary thyroid carcinoma using next-generation sequencing.
• Utilized next-generation sequencing to analyze genetic alterations.
• Identified ARAP3 as a potential novel oncogene in papillary thyroid carcinoma.
• The findings suggested ARAP3's role as an oncogene, but are now questioned due to image duplication issues.